EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TONSL promotes hepatocellular carcinoma progression and radioresistance by orchestrating DNA damage repair and cell cycle dynamics

Min-Rui Luo, Jia-Lin Liao, Shu-Jie Fang, Dong-Yan Zhang, Ling Lei

Discover Oncology · 12.03.2026 · 17 (1)

DOI: 10.1007/s12672-026-04698-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 12.03.2026. Verfasst von Min-Rui Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Nature Science Foundation of China, the Natural Science Foundation of Guangdong Province, Cancer Hospital Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Hepatocellular carcinomaPrognostic biomarkerRadioresistanceSorafenib resistanceTONSL

Autor:innen und Institutionen

  • Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
  • Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. 15013091401@163.com.
  • National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China. 18588535764@163.com.

Förderung

  • the National Nature Science Foundation of China
  • the Natural Science Foundation of Guangdong Province
  • Cancer Hospital Chinese Academy of Medical Sciences
  • National High Level Hospital Clinical Research Funding and Cooperation Fund of CHCAMS and SZCH
  • the Shenzhen Science and Technology Program

Zitieren

APA

Luo, M. R., Liao, J. L., Fang, S. J., Zhang, D. Y., & Lei, L. (2026). TONSL promotes hepatocellular carcinoma progression and radioresistance by orchestrating DNA damage repair and cell cycle dynamics. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04698-7

Vancouver

Luo MR, Liao JL, Fang SJ, Zhang DY, Lei L. TONSL promotes hepatocellular carcinoma progression and radioresistance by orchestrating DNA damage repair and cell cycle dynamics. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04698-7

BibTeX
@article{Luo2026,
  author = {Luo, Min-Rui and Liao, Jia-Lin and Fang, Shu-Jie and Zhang, Dong-Yan and Lei, Ling},
  title = {TONSL promotes hepatocellular carcinoma progression and radioresistance by orchestrating DNA damage repair and cell cycle dynamics},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04698-7}
}
Kostenlos starten →